Evidence map›Paper›PMID 30333422›Full record

SynthesisInternal medicine (Tokyo, Japan)2019

Systemic Lupus Erythematosus Associated with Ovarian Cancer.

Mayu Yagita, Saori Hata, Hiromi Miyata, Hiroko Kakita, Tatsuo Tsukamoto, Eri Muso, Masaaki Fujita

Open access · diamondAbstract readCase ReportsSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mayu YagitaDepartment of Clinical Immunology and Rheumatology, The Tazuke-Kofukai Medical Research Institute, Kitano Hospital, Japan.
Saori HataDepartment of Obstetrics and Gynecology, The Tazuke-Kofukai Medical Research Institute, Kitano Hospital, Japan.
Hiromi MiyataDepartment of Obstetrics and Gynecology, The Tazuke-Kofukai Medical Research Institute, Kitano Hospital, Japan.
Hiroko KakitaDepartment of Nephrology and Dialysis, The Tazuke-Kofukai Medical Research Institute, Kitano Hospital, Japan.
Tatsuo TsukamotoDepartment of Nephrology and Dialysis, The Tazuke-Kofukai Medical Research Institute, Kitano Hospital, Japan.
Eri MusoDepartment of Nephrology and Dialysis, The Tazuke-Kofukai Medical Research Institute, Kitano Hospital, Japan.
Masaaki FujitaDepartment of Clinical Immunology and Rheumatology, The Tazuke-Kofukai Medical Research Institute, Kitano Hospital, Japan.
Kitano Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) may be associated with various types of malignancy. However, SLE occurring with ovarian cancer seems rare, and reliable therapeutic approaches for such cases have yet to be identified. We herein report a case of SLE with ovarian cancer that was successfully treated with corticosteroid, plasmapheresis and chemotherapy. This case may provide new insights into treatment approaches for SLE with ovarian cancer.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyFemaleGlucocorticoidsHumansHysterectomyLupus Erythematosus, SystemicMagnetic Resonance ImagingMiddle AgedOvarian NeoplasmsPlasmapheresisPositron Emission Tomography Computed TomographyGlucocorticoidsmalignancyovarian cancersystemic lupus erythematosus

Identifiers

PMID30333422
PMCPMC6443548
OpenAlexW2897411761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.